MedTrace Logo

Orange Juice Supplementation in Soccer Players

NCT03209596 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-07-11

No results posted yet for this study

Summary

This study aimed to verify if orange juice supplementation can be a nutritional strategy to ensure an adequate energy and micronutrients ingestion, influencing metabolic responses of soccer players.

Conditions

  • Healthy Athletes

Interventions

DIETARY_SUPPLEMENT

Orange juice (1L/d)

The players (n=17) drank 1 liter per day of orange juice. We do not interfere on the volunteers' usual diet during the study, and they did not ingest any commercial nutritional supplements in this period. During the intervention, the volunteers were engaged in a common training routine specified by the coach's team.

DIETARY_SUPPLEMENT

Control drink (1L/d)

The players (n=13) drank 1 liter per day of the control drink during a 60-day period. We do not interfere on the volunteers' usual diet during the study, and they did not ingest any commercial nutritional supplements in this period. During the intervention, the volunteers were engaged in a common training routine specified by the coach's team.

Sponsors & Collaborators

  • Citrosuco Company

    collaborator INDUSTRY

  • Ellen Cristini de Freitas

    lead OTHER

Principal Investigators

  • Ellen C De Freitas, Ph.D. · University of São Paulo, School of Physical Education and Sports of Ribeirão Preto

  • Sara M Terrazas, Msc · Sao Paulo State University "Julio de Mesquita Filho", Faculty of Pharmaceutical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
19 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-20
Primary Completion
2014-01-31
Completion
2014-08-29

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03209596 on ClinicalTrials.gov